Neurologic complications in ICU patients often have a substantial negative impact on their outcome. Neurologists are being asked increasingly to evaluate patients in intensive care units. They are often called to assess unusual neurologic manifestations of other primary diseases, evaluate the consequences of critical care therapy, offer a prognosis, or determine brain death. Using a case-based approach, faculty will provide the core elements of modern neurologic critical care and suggested approach to the management of some of the most commonly encountered problems. Topics will include: approach to neurologic problems in the ICU, including failure to awaken after cardiac arrest; brain death; neuromuscular considerations in the ICU; difficulty-to-wean off artificial ventilation; and epilepsy, including status epilepticus. Interactions between faculty and participants will be encouraged.
Participants should have a comprehensive understanding of the general aspects of critical care of neurologic patients and common neurologic problems encountered in the ICU setting, be able to incorporate evidence-driven data into their recommendations, and be able to evaluate and treat common disorders in the ICU and provide an opinion regarding prognosis.
Interpersonal and Communication Skills, Medical Knowledge, Patient Care, Practice-Based Learning and Improvement, Professionalism, Systems-Based Practice
Program Speakers - Tentative
6:00 PM - 7:00 PM
Case Studies in Coma and Brain Death
David M. Greer MD, FAAN
7:00 PM - 8:00 PM
Case Studies in Epilepsy and Status Epilepticus
Julie Roth MD
8:00 PM - 9:00 PM
Case Studies in Neuromuscular Disorders in the ICU
Nicholas Joseph Silvestri MD, FAAN
David M. Greer, MD, FAAN
Dr. Greer has received personal compensation in an editorial capacity for Thieme.
Julie Roth, MD
Dr. Roth has nothing to disclose.
Nicholas Joseph Silvestri, MD, FAAN
Dr. Silvestri has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Alexion Pharmaceuticals and OptionCare.